Daniel Lachant

19PUBLICATIONS
16CO-AUTHORS
Behavioural epidemiologyCell physiologyPharmacogenomicsExercise physiologyBiomedical fluid mechanics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (19)

|Apr 13, 2026
Rodatristat ethyl decreases activity in pulmonary arterial hypertension: results from the ELEVATE-2 trial.

Daniel J Lachant, Sandeep Sahay, Robert Block

|Mar 10, 2026
Longitudinal Remote 6-Minute Walk Distance and Cardiac Effort Using Wearable Sensors in Pulmonary Hypertension.

Daniel Lachant, Nishit Agarwal, Kyle Norton

|Feb 02, 2026
Efficacy and Safety of Oral Treprostinil in Patients with Pulmonary Arterial Hypertension on Background Monotherapy or Dual Therapy.

Daniel Lachant, Amresh Raina, Mrinalini Krishnan

|Jan 20, 2026
Supplemental Oxygen Decreases Cardiac Effort in Pulmonary Arterial Hypertension.

Kyle Norton, Bishal Gyawali, Deborah Haight

|Dec 22, 2025
Real-World Dosing and Persistence of Oral Treprostinil Initiation Strategies in Patients With Pulmonary Arterial Hypertension.

Daniel J Lachant, Ali Ataya, H James Ford

|Sep 29, 2025
Letter by White et al Regarding Article, "Large-Bore Mechanical Thrombectomy Versus Catheter-Directed Thrombolysis in the Management of Intermediate-Risk Pulmonary Embolism: Primary Results of the PEERLESS Randomized Controlled Trial".

R James White, Dominick Roto, Daniel Lachant

Pageof 4

Frequent Collaborators

7 joint publications

R James White

1 joint publications

Scott Seaman

1 joint publications

Benjamin Wu

1 joint publications

Sandeep Sahay